These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18353887)

  • 1. Time-dependent effect of sevelamerHCl on the cardiovascular system.
    Savica V; Monardo P; Santoro D; Mallamace A; Bellinghieri G
    Nephrol Dial Transplant; 2008 Jun; 23(6):2102-3; author reply 2103. PubMed ID: 18353887
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.
    Chan D; Irish A; Croft KD; Dogra G
    Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285
    [No Abstract]   [Full Text] [Related]  

  • 3. Parathyroidectomy and improving anemia.
    Jemcov TK; Petakov M; Bogdanovic A; Djukanovic L; Lezaic VD
    Arch Surg; 2008 Jan; 143(1):97-8. PubMed ID: 18209161
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis.
    Cheng Y; Tu W; Xiao Q; Chen Y; Hu L; Wu X
    Int J Cardiol; 2014 Jul; 174(3):780-3. PubMed ID: 24768378
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic kidney disease: the new silent killer.
    Kopyt NP
    J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380
    [No Abstract]   [Full Text] [Related]  

  • 6. Parenteral nutrition offers no benefit over oral supplementation in malnourished hemodialysis patients.
    Ikizler TA
    Nat Clin Pract Nephrol; 2008 Feb; 4(2):76-7. PubMed ID: 17998928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morbidity in hemodialysis].
    Galindo P; Martínez Sánchez T; Osuna A; Asensio C
    Nefrologia; 2002; 22(2):202-3. PubMed ID: 12085423
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of the impact of hepatitis C virus on insulin resistance and arterial stiffness in hemodialysis patients.
    Adam FU; Torun D; Yigit F; Ozelsancak R; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2008; 30(4):411-5. PubMed ID: 18569915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z
    Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
    Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
    Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up.
    de Vries WB; Karemaker R; Mooy NF; Strengers JL; Kemperman H; Baerts W; Veen S; Visser GH; Heijnen CJ; van Bel F
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):738-44. PubMed ID: 18678806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil and mild hyperkalemia in hemodialysis patients: a potentially hazardous association.
    Letavernier E; Couzi L; Delmas Y; Moreau K; Murcott O; de Précigout V
    Hemodial Int; 2006 Apr; 10(2):170-2. PubMed ID: 16623670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
    Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
    Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial compliance in adolescents and young adults receiving chronic hemodialysis.
    Gbadegesin R; Kudelka T; Gadegbeku CA; Brophy P; Smoyer WE; Lin JJ
    Ren Fail; 2008; 30(6):591-6. PubMed ID: 18661408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
    Olgaard K; Lewin E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1786-9; discussion 1789-3. PubMed ID: 18400819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.